Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Tolerability of TAR-200 in Subjects With Muscle-Invasive Bladder Cancer Who Are Unfit for Radical Cystectomy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03404791
Recruitment Status : Recruiting
First Posted : January 19, 2018
Last Update Posted : April 23, 2019
Sponsor:
Information provided by (Responsible Party):
Taris Biomedical LLC

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2020
Estimated Study Completion Date : March 2020